マーケットレポート詳細

喘息向け生物学的製剤(Asthma Biologics)の世界市場：2031年予測

Asthma Biologics Market (Drug Class: Selective Immuno-suppressants, Interleukin Inhibitors, and Others; Distribution Channel: Retail Pharmacies, E-commerce, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版元：Transparency Market Research 　 出版元について
発行年：2023年10月
定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文148ページになります。
商品コード：TMR090

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

喘息向け生物学的製剤の世界市場規模は2022年で65億ドル、2031年に192億ドル、市場の平均年成長率は12.5%になると予想されています。

当レポートでは、喘息向け生物学的製剤の市場予測-2031年、各種セグメント別市場分析(薬物クラス別、販売経路別、国地域別、等)、市場ダイナミクス、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■喘息向け生物学的製剤の世界市場予測2017-2031年

・市場規模(US$)

■薬物クラス別、市場-2031年

選択的免疫抑制剤
インターロイキン阻害薬
その他
※(市場規模US$)

■販売経路別、市場-2031年

小売薬局
Eコマース
その他
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・スペイン、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析

■喘息向け生物学的製剤の主要企業プロフィール動向

Amgen, Inc.
AstraZeneca
F. Hoffmann-La Roche Ltd.
GSK plc
Novartis AG
Regeneron Pharmaceuticals, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
その他企業

（全148頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
3. Executive Summary : Global Asthma Biologics Market
4. Market Overview

    4.1. Introduction
        4.1.1. Drug Class Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Asthma Biologics Market Analysis and Forecast, 2017 - 2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Pipeline Analysis
    5.2. T2 Inflammation Disease State Overview
    5.3. Disease Prevalence Rate with Key Countries
    5.4. COVID-19 Pandemics Impact on Industry

6. Global Asthma Biologics Market Analysis and Forecast, by Drug Class

    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Drug Class, 2017 - 2031
        6.3.1. Selective Immunosuppressants
        6.3.2. Interleukin Inhibitors
        6.3.3. Others
    6.4. Market Attractiveness, by Drug Class

7. Global Asthma Biologics Market Analysis and Forecast, by Distribution Channel

    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        7.3.1. Retail Pharmacies
            7.3.1.1. E-commerce
            7.3.1.2. Others
    7.4. Market Attractiveness, by Distribution Channel

8. Global Asthma Biologics Market Analysis and Forecast, by Region

    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness, by Country/Region

9. North America Asthma Biologics Market Analysis and Forecast

    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Drug Class, 2017 - 2031
        9.2.1. Selective Immunosuppressants
        9.2.2. Interleukin Inhibitors
        9.2.3. Others
    9.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        9.3.1. Retail Pharmacies
        9.3.2. E-commerce
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017 - 2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Drug Class
        9.5.2. By Distribution Channel
        9.5.3. By Country

10. Europe Asthma Biologics Market Analysis and Forecast

    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Drug Class, 2017 - 2031
        10.2.1. Selective Immunosuppressants
        10.2.2. Interleukin Inhibitors
        10.2.3. Others
    10.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        10.3.1. Retail Pharmacies
            10.3.1.1. E-commerce
            10.3.1.2. Others
    10.4. Market Value Forecast, by Country, 2017 - 2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Drug Class
        10.5.2. By Distribution Channel
        10.5.3. By Country

11. Asia Pacific Asthma Biologics Market Analysis and Forecast

    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Drug Class, 2017 - 2031
        11.2.1. Selective Immunosuppressants
        11.2.2. Interleukin Inhibitors
        11.2.3. Others
    11.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        11.3.1. Retail Pharmacies
            11.3.1.1. E-commerce
            11.3.1.2. Others
    11.4. Market Value Forecast, by Country, 2017 - 2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Drug Class
        11.5.2. By Distribution Channel
        11.5.3. By Country

12. Latin America Asthma Biologics Market Analysis and Forecast

    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Drug Class, 2017 - 2031
        12.2.1. Selective Immunosuppressants
        12.2.2. Interleukin Inhibitors
        12.2.3. Others
    12.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        12.3.1. Retail Pharmacies
            12.3.1.1. E-commerce
            12.3.1.2. Others
    12.4. Market Value Forecast, by Country, 2017 - 2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Drug Class
        12.5.2. By Distribution Channel
        12.5.3. By Country

13. Middle East & Africa Asthma Biologics Market Analysis and Forecast

    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Drug Class, 2017 - 2031
        13.2.1. Selective Immunosuppressants
        13.2.2. Interleukin Inhibitors
        13.2.3. Others
    13.3. Market Value Forecast, by Distribution Channel, 2017 - 2031
        13.3.1. Retail Pharmacies
            13.3.1.1. E-commerce
            13.3.1.2. Others
    13.4. Market Value Forecast, by Country, 2017 - 2031
        13.4.1. GCC
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Drug Class
        13.5.2. By Distribution Channel
        13.5.3. By Country

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)
    14.2. Market Share Analysis By Company (2021)
    14.3. Company Profiles
        14.3.1. Amgen, Inc.
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. Strategic Overview
            14.3.1.5. SWOT Analysis
        14.3.2. AstraZeneca
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. Strategic Overview
            14.3.2.5. SWOT Analysis
        14.3.3. F. Hoffmann-La Roche Ltd.
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. Strategic Overview
            14.3.3.5. SWOT Analysis
        14.3.4. GSK plc
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. Strategic Overview
            14.3.4.5. SWOT Analysis
        14.3.5. Novartis AG
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. Strategic Overview
            14.3.5.5. SWOT Analysis
        14.3.6. Regeneron Pharmaceuticals, Inc.
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. Strategic Overview
            14.3.6.5. SWOT Analysis
        14.3.7. Sanofi
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. Strategic Overview
            14.3.7.5. SWOT Analysis
        14.3.8. Teva Pharmaceutical Industries Ltd.
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. Strategic Overview
            14.3.8.5. SWOT Analysis

List of Tables

Table 01: Global Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 02: Global Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 03: Global Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: North America Asthma Biologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 06: North America Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 07: Europe Asthma Biologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: Europe Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 09: Europe Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 10: Asia Pacific Asthma Biologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 11: Asia Pacific Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 12: Asia Pacific Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Latin America Asthma Biologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 14: Latin America Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 15: Latin America Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 16: Middle East & Africa Asthma Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Asthma Biologics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 18: Middle East & Africa Asthma Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Asthma Biologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 03: Global Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 04: Global Asthma Biologics Market Revenue (US$ Mn), by Selective Immuno-suppressants, 2017–2031

Figure 05: Global Asthma Biologics Market Revenue (US$ Mn), by Interleukin Inhibitors, 2017–2031

Figure 06: Global Asthma Biologics Market Revenue (US$ Mn), by Others, 2017–2031

Figure 07: Global Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 08: Global Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

Figure 09: Global Asthma Biologics Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2031

Figure 10: Global Asthma Biologics Market Revenue (US$ Mn), by E-commerce, 2017–2031

Figure 11: Global Asthma Biologics Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: Global Asthma Biologics Market Value Share Analysis, by Region, 2022 and 2031

Figure 13: Global Asthma Biologics Market Attractiveness, by Region, 2023-2031

Figure 14: North America Asthma Biologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 15: North America Asthma Biologics Market Value Share (%), by Country, 2022 and 2031

Figure 16: North America Asthma Biologics Market Attractiveness Analysis, by Country, 2023–2031

Figure 17: North America Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 18: North America Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 19: North America Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 20: North America Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

Figure 21: Europe Asthma Biologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 22: Europe Asthma Biologics Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 23: Europe Asthma Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 24: Europe Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 25: Europe Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 26: Europe Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 27: Europe Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

Figure 28: Asia Pacific Asthma Biologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: Asia Pacific Asthma Biologics Market Value Share (%), by Country, 2022 and 2031

Figure 30: Asia Pacific Asthma Biologics Market Attractiveness Analysis, by Country, 2023–2031

Figure 31: Asia Pacific Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 32: Asia Pacific Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 33: Asia Pacific Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 34: Asia Pacific Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

Figure 35: Latin America Asthma Biologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 36: Latin America Asthma Biologics Market Value Share (%), by Country, 2022 and 2031

Figure 37: Latin America Asthma Biologics Market Attractiveness Analysis, by Country, 2023–2031

Figure 38: Latin America Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 39: Latin America Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 40: Latin America Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 41: Latin America Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

Figure 42: Middle East & Africa Asthma Biologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 43: Middle East & Africa Asthma Biologics Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 44: Middle East & Africa Asthma Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 45: Middle East & Africa Asthma Biologics Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 46: Middle East & Africa Asthma Biologics Market Attractiveness, by Drug Class, 2023-2031

Figure 47: Middle East & Africa Asthma Biologics Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 48: Middle East & Africa Asthma Biologics Market Attractiveness, by Distribution Channel, 2023-2031

△ 一番上に戻る